Recently, two randomized controlled trials (RCTs) demonstrated that tirzepatide, a dual GLP-1/GIP receptor agonists, reduced the AHI and hypoxic burden, and improved sleep-related patient-reported outcomes among individuals with moderate-to-severe OSA [24]
Patients taking GLP-1 medications with insulin or sulfonylureas have an increased risk of hypoglycemia and should discuss timing of all medications with their healthcare provider to minimize this risk
With a combination of better-for-you groceries and meal kits that utilize them, most Hungryroot meals come together in under 20 minutes
* Cotton balls or gauze: Used for cleaning the area of injection and covering it post-donation
In a trial in people with metabolic syndrome, pasteurized Akkermansia increased GLP-1 ( Suenaert et al., 2026 (Human trial)
UCB reported in October 2021 that the FDA had to delay its verdict on the drugs Biologics License Application because it was unable to conduct on-site facility inspections due to travel restrictions